NCT05003973

Brief Summary

Background: The incidence of lower limb lymphedema (LLL) after gynecological cancer surgery with lymphadenectomy is about 10-46%. Lower limb lymphedema results in limited physical mobility and reduced patients' quality of life. A hospital -based complete decongestive therapy has been recommended to patients with LLL, including exercise, manual lymphatic drainage, compression therapy, and skin care. However, the inconvenience of the hospital-based rehabilitation program limit the availability for those patients LLL. Home-based exercise program may be feasible instead of the hospital-based program. Few studies have evaluated the effectiveness of the home-based lower extremity exercise on reliving LLL and improving quality of life in patients with LLL. Research Purposes: The main purpose of the study is to evaluate the effectiveness of a home-based exercise program for relieving lower extremity lymphedema, including circumference measurement, bioimpedance spectroscopy (BIS), lower limb muscle strength, quality of life related to cancer \& LLL, and fatigue. Methods: This study is a two- year project with a single-blind randomized clinical trial. The participants are women with gynecological cancer surgery, aged of 20-75 years and currently have lower extremity lymphedema. A sample of 76 participants will be stratified randomly assigned to an experimental group or a control group. The experimental group is to carry out a home-based anti-resistance exercise with elastic band other than a routine care of complex decongestive physiotherapy; while the control group is to carry out a routine care of complex decongestive physiotherapy. The home-based program is a 12-week exercise program. Data collections will be conducted before exercise (Baseline), during exercise (second months), and exercise program after completion. Measures includes (1) Physical examination: limb leg circumference measurement, bioimpedance spectroscopy (BIS), lower limb muscle strength, (2) Questionnaires: Functional status of lymphatic edema of LLL, fatigue, and EORTC-QLQ-C30. Anticipated Outcomes: Findings from this study could provide a reference of home-based exercise guideline and be integrated into the care of activities for women following gynecological surgery with LLL.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 13, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

August 20, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

August 13, 2021

Status Verified

August 1, 2021

Enrollment Period

1.4 years

First QC Date

July 26, 2021

Last Update Submit

August 12, 2021

Conditions

Keywords

Women's HealthHome-based Anti-Resistance Exercise

Outcome Measures

Primary Outcomes (6)

  • Limb circumference change from baseline to 3 months

    Measuring by measuring tape

    from baseline to 3 months

  • Edema change from baseline to 3 months

    Measuring by Bioelectrical Impedance Spectroscopy (BIS)- InBody S10

    from baseline to 3 months

  • Lower limb muscle strength change from baseline to 3 months

    Measuring by microFET 2

    from baseline to 3 months

  • Functional status of lymphatic edema of LLL change from baseline to 3 months

    Measuring by Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL). It is a 28-item, 0(no problem) to 10(very severe) questionnaire.

    from baseline to 3 months

  • Fatigue change from baseline to 3 months

    Measuring by Chinese Lee Fatigue Scale Short Form (C-LESSF). It is a 7-item, from 0(no fatigue) to 10(very fatigue) questionnaire.

    from baseline to 3 months

  • EORTC-QLQ-C30

    Measuring by EORTC QLQ C30. It is a 30-item, from 0(no problem) to 10(very severe) questionnaire.

    from baseline to 3 months

Study Arms (2)

home-based anti-resistance exercise

EXPERIMENTAL
Behavioral: home-based anti-resistance exerciseBehavioral: usually care

usually care

EXPERIMENTAL
Behavioral: usually care

Interventions

It is a 12-week, middle-level, home-based, anti-resistance exercise. Exercise was recommended 1-2 times per day for 15-20 mins per session.

home-based anti-resistance exercise
usually careBEHAVIORAL

The leaflet of the lymphedema self-care, including skin care and manual lymphatic drainage

home-based anti-resistance exerciseusually care

Eligibility Criteria

Age20 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women with gynecological cancer surgery
  • aged of 20-75 years
  • currently have lower extremity lymphedema.

You may not qualify if:

  • heart failure
  • kidney failure
  • DVT
  • limb surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Ernst M, Wagner C, Oeser A, Messer S, Wender A, Cryns N, Brockelmann PJ, Holtkamp U, Baumann FT, Wiskemann J, Monsef I, Scherer RW, Mishra SI, Skoetz N. Resistance training for fatigue in people with cancer. Cochrane Database Syst Rev. 2024 Nov 28;11(11):CD015518. doi: 10.1002/14651858.CD015518.

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 26, 2021

First Posted

August 13, 2021

Study Start

August 20, 2021

Primary Completion

December 31, 2022

Study Completion

December 31, 2023

Last Updated

August 13, 2021

Record last verified: 2021-08